Long-term faecal incontinence following the use of botulinum toxin.
Smith
M
M
Frizelle
F
F
D015746:Abdominal Pain / Q000175:diagnosis / Q000209:etiology; D000328:Adult; D001003:Anal Canal / Q000187:drug effects; D019274:Botulinum Toxins, Type A / Q000009:adverse effects* / Q000627:therapeutic use; D005242:Fecal Incontinence / Q000139:chemically induced* / Q000503:physiopathology; D006801:Humans; D015552:Injections, Intralesional; D008297:Male; D008365:Manometry; D011379:Prognosis; D012005:Rectal Prolapse / Q000175:diagnosis / Q000188:drug therapy*; D018570:Risk Assessment; D012720:Severity of Illness Index; D013997:Time Factors
D019274:Botulinum Toxins, Type A